An urgent warning has been issued regarding the spread of a dangerous new drug dubbed ‘Russian Roulette’ pink cocaine in the UK. The synthetic drug, pink cocaine, has become a major concern after emerging in Spain and is now causing alarm in the UK. Spanish authorities recently conducted their largest-ever synthetic drug bust, seizing a significant quantity of pink cocaine along with over a million ecstasy pills in operations targeting drug networks in Ibiza and Malaga.
Experts have highlighted the dangerous and unpredictable nature of pink cocaine, which has been linked to a rising number of drug-related deaths. Despite its name, pink cocaine does not necessarily contain cocaine but is a mix of various substances including MDMA, ketamine, and 2C-B. These substances have different effects, with MDMA being a stimulant with psychedelic properties, ketamine being a powerful anaesthetic with sedative and hallucinogenic effects, and 2C-B being a psychedelic drug that can also act as a stimulant.
Pink cocaine, often found in powder or pill form, is known for its vibrant colour, designed to enhance its visual appeal. The drug first emerged in Colombia in 2010 as a knock-off version of the original psychedelic form from 1974 and gained popularity in Latin America before spreading to Europe. It goes by various names such as “cocaina rosada,” “tuci,” “Venus,” and “Eros.” The unpredictable mix of substances in pink cocaine poses significant health risks, especially since users may not be aware of its full composition and effects.
Health officials are particularly concerned about the drug’s presence in the UK, with reports indicating its spread to Scotland, parts of Wales, and England, as well as an increase in availability in New York City. European authorities are finding it challenging to detect pink cocaine through standard drug testing due to its complex composition, making it difficult to identify all its components accurately.
In response to the rise of pink cocaine, there is a growing need for accessible drug-checking services to help users identify potentially harmful substances. These services can play a vital role in harm reduction by allowing individuals to test the drugs they intend to consume and learn about any unknown components present. Public awareness campaigns and support services are also crucial in reducing the risks associated with pink cocaine use and addressing its growing popularity among young people and first-time users.
As pink cocaine continues to pose a serious and evolving threat in Europe and beyond, authorities, health services, and the public must work together to address the dangers it presents. The allure of its pink hue and ‘designer’ label may attract a younger crowd, but the unpredictable cocktail of chemicals it contains underscores the importance of raising awareness and taking action to mitigate the risks associated with this dangerous drug.